HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Cappelletti Selected Research

Cristina Cappelletti Research Topics

Disease

3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2018 - 11/2005
3Muscular Dystrophies (Muscular Dystrophy)
01/2018 - 11/2005
2Muscular Diseases (Myopathy)
11/2023 - 01/2018
2Laminopathies
01/2020 - 01/2018
2Inflammation (Inflammations)
06/2019 - 12/2011
2Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2018 - 11/2005
2Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
01/2018 - 01/2018
2Fibrosis (Cirrhosis)
12/2011 - 11/2005
1Polyps
03/2024
1Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
09/2023
1Aphasia (Dysphasia)
10/2019
1Encephalitis (Encephalitis, Rasmussen)
10/2019
1Partial Epilepsies (Epilepsy, Partial)
10/2019
1Relapsing-Remitting Multiple Sclerosis
10/2019
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2019
1Autoimmune Diseases of the Nervous System
10/2019
1Epileptic Syndromes
06/2019
1Seizures (Absence Seizure)
06/2019
1Infections
06/2019
1Oculopharyngeal Muscular Dystrophy
01/2019
1type 1B Limb-girdle muscular dystrophy
01/2018
1Lmna-Related Congenital Muscular Dystrophy
01/2018
1Inclusion Body Myositis
01/2018
1Myasthenia Gravis
08/2014
1Necrosis
12/2011
1Myositis (Idiopathic Inflammatory Myopathies)
06/2008
1Infarction (Infarctions)
01/2008
1Cardiovascular Diseases (Cardiovascular Disease)
01/2008
1Sarcoglycanopathies
11/2005
1Dysferlinopathy
11/2005
1Neuromuscular Diseases (Neuromuscular Disease)
11/2005

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
09/2023 - 11/2005
3Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2018
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2023 - 01/2018
2perlecanIBA
09/2023 - 11/2005
2CytokinesIBA
01/2020 - 11/2005
2Messenger RNA (mRNA)IBA
01/2019 - 11/2005
2CollagenIBA
12/2011 - 11/2005
1Environmental DNAIBA
03/2024
1Interleukin-7 (Interleukin 7)IBA
11/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Interleukin-4 (Interleukin 4)IBA
01/2020
1ChemokinesIBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1Inosine Triphosphate (ITP)IBA
10/2019
1Alemtuzumab (Campath)FDA Link
10/2019
1AntibodiesIBA
10/2019
1SteroidsIBA
10/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2019
1Therapeutic UsesIBA
06/2019
1InterleukinsIBA
06/2019
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Lamin Type A (Lamin A)IBA
01/2018
1Toll-Like Receptor 4IBA
08/2014
1Matrix Metalloproteinases (MMPs)IBA
12/2011
1OsteopontinIBA
12/2011
1KinesinsIBA
06/2008
1DecorinIBA
11/2005
1DysferlinIBA
11/2005
1BiglycanIBA
11/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2005
1Proteoglycans (Proteoglycan)IBA
11/2005
1Sarcoglycans (beta Sarcoglycan)IBA
11/2005

Therapy/Procedure

2Therapeutics
10/2019 - 01/2008
1Stem Cell Transplantation
01/2008
1Cell Transplantation
01/2008